Skip to content
healthcare.dev

Qbrelis

NDC 52652-3001, lisinopril, solution, from Azurity Pharmaceuticals, Inc..

Product NDC
52652-3001
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208401
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52652-3001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISINOPRIL1 mg/mL

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]

Package NDCNDC-11Package
52652-3001-152652300101150 mL in 1 BOTTLE (52652-3001-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9f6e4e57-a489-4b36-b093-b93865d3717c
  • NADAC price for package 52652300101

    GET /v1/drugs/nadac/52652300101

Use it

Look up 52652-3001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52652-3001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52652-3001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.